Suchergebnisse - "Subbiah, Vivek"

PubPharm (568)

31

The Landscape of Alterations from 1407 Ultra-Rare Sarcomas from the AACR GENIE Database : Clinical Implications

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Denu, R. | Moyers, J. | Gouda, M. | +3

32

Clouds across the new dawn for clinical, diagnostic and biological data : accelerating the development, delivery and uptake of personalized medicine

enthalten in: Diagnosis (Berlin, Germany) | 2023

von Horgan, D. | Capoluongo, E. | Dube, F. | +10

33

Tumor-agnostic drug development in dMMR/MSI-H solid tumors

enthalten in: Trends in cancer | 2023

von Bhamidipati, D. | Subbiah, V.

34

Pooled Safety Analysis of Single-Agent Lurbinectedin in Patients With Advanced Solid Tumours

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Leary, A. | Oaknin, A. | Trigo, J. | +10

35

Transporting Comparative Effectiveness Evidence Between Countries: Considerations for Health Technology Assessments

enthalten in: PharmacoEconomics | 2023

von Turner, A. | Sammon, C. | Latimer, N. | +5

36

Immune-checkpoint inhibition for resectable non-small-cell lung cancer - opportunities and challenges

enthalten in: Nature reviews. Clinical oncology | 2023

von Mountzios, G. | Remon, J. | Hendriks, L. | +9

37

Clinical development and management of adverse events associated with FGFR inhibitors

enthalten in: Cell reports. Medicine | 2023

von Subbiah, V. | Verstovsek, S.

38

Pearls and pitfalls of ChatGPT in medical oncology

enthalten in: Trends in cancer | 2023

von Blum, J. | Menta, A. | Zhao, X. | +3

39

Lurbinectedin in patients with pretreated endometrial cancer : results from a phase 2 basket clinical trial and exploratory translational study

enthalten in: Investigational new drugs | 2023

von Kristeleit, R. | Leary, A. | Delord, J. | +15

40

RETooling the RET Inhibitor Pralsetinib for ESR1 Fusion-Positive Breast Cancer and Beyond

enthalten in: Cancer research | 2023

von Wu, J. | Subbiah, V.

CommentOn: Cancer Res. 2023 Oct 2;83(19):3237-3251. - PMID 37071495